2-Mercaptobenzenesulphonamides as novel inhibitors of human Immunodeficiency virus type 1 integrase and replication

Antiviral Chemistry and Chemotherapy

Volumn 8, Issue 6, 1997, Pages 485-495

  Neamati, N ^a   Mazumder, A ^a   Sunder, S ^a   Owen, J M ^a   Schultz, R J ^a   Pommier, Y ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

HIV; Inhibitors; Integrase; Sulphonamides

Indexed keywords

2 MERCAPTOBENZENESULFONAMIDE; ANTIVIRUS AGENT; ENZYME INHIBITOR; INTEGRASE; SULFONAMIDE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CHEMOTHERAPY; CONTROLLED STUDY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; VIRUS INHIBITION;

EID: 0030867109     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029700800602     Document Type: Article

References (30)

1. Burke TR, Fesen M, Mazumder A, Yung J, Wang J, Carothers AM, Grunberger D, Driscoll J & Pommier Y (1995) Hydroxylated aromatic inhibitors of HIV-1 integrase. Journal of Medicinal Chemistry 38: 4171-4178.
2. Drake R, Neamati N, Sunthankar P, Mazumder A & Pommier Y (1997) Identification of the antiviral nucleoside drug binding site of HIV-1 integrase by proteolytic peptide mapping. Antiviral Research 34: A42.
3. Eich E, Pertz H, Kaloga M, Schulz J, Fesen MR, Mazumder A & Pommier Y (1996) (-)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase. Journal of Medicinal Chemistry 39: 86-95.
4. Fesen MR, Kohn KW, Leteurtre F & Pommier Y (1993) Inhibitors of human immunodeficiency virus integrase. Proceedings of the National Academy of Sciences, USA 90: 2399-2403.
5. Fesen MR, Pommier Y, Leteurtre F, Hiroguchi S, Yung J & Kohn KW (1994) Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochemical Pharmacology 48: 595-608.
6. Hong H, Neamati N, Wang S, Nicklaus MC, Mazumder A, Pommier Y, Zhao H, Burke TR Jr & Milne GWA (1997) Discovery of human immunodeficiency virus type 1 integrase inhibitors by pharmacophore searching. Journal of Medicinal Chemistry 40: 930-936.
7. Katz RA & Skalka AM (1994) The retroviral enzymes. Annual Review of Biochemistry 63: 133-173.
8. Mahmood N, Moore PS, De Tommasi N, De Simone F, Colman S, Hay AJ & Pizza C (1993) Inhibition of HIV infection by caffeoylquinic acid derivatives. Antiviral Chemistry and Chemotherapy 4: 235-240.
9. Mazumder A, Neamati N, Sommadossi J-P, Gosselin G, Schinazi RF, Imbach JL & Pommier Y (1996a) Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase. Molecular Pharmacology 49: 621-628.
10. Mazumder A, Neamati N, Ojwang JO, Sunder S, Rando RF & Pommier Y (1996b) Inhibition of the human immunodeficiency virus type 1 integrase by guanosine quartet structures. Biochemistry 35: 13762-13771.
11. Mazumder A, Wang S, Neamati N, Nicklaus M, Sunder S, Chen J, Milne GW, Rice WG, Burke TR Jr & Pommier, Y (1996c) Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease. Journal of Medicinal Chemistry 39: 2472-2481.
12. Mazumder A, Uchida H, Neamati N, Sunder S, Jaworska-Maslanka M, Wickstrom E, Zeng F, Jones RA, Mandes RF, Chenault HK & Pommier Y (1997a) Probing interactions between viral DNA and human immunodeficiency virus type 1 integrase using dinucleotides. Molecular Pharmacology 51: 567-575.
13. Mazumder A, Neamati N, Sunder S, Owen J & Pommier Y (1997b) Retroviral integrase: a novel target in antiviral development; basic in vitro assays with the purified enzyme. In Methods in Cellular and Molecular Biology: Antiviral Evaluation. Edited by D Kinchington and R Schinazi. Totowa, New Jersey: Humana Press (in press).
14. Neamati N, Sunder S & Pommier Y (1997a) Design and discovery of HIV-1 integrase inhibitors. Drug Discovery Today 2:487-498.
15. Neamati N, Hong H, Mazumder A, Wang S, Sunder S, Nicklaus MC, Milne GWA, Proksa B & Pommier Y (1997b) Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching. Journal of Medicinal Chemistry 40: 942-951.
16. Neamati N, Mazumder A, Zhao H, Sunder S, Burke J, Schultz RJ & Pommier, Y (1997c) Diarylsulfones, a novel class of human immunodeficiency type 1 integrase inhibitors. Antimicrobial Agents and Chemotherapy 41: 385-393.
17. Nicklaus MC, Neamati N, Hong H, Mazumder A, Sunder S, Chen J, Milne GWA & Pommier Y (1997) HIV-1 integrase pharmacophore: discovery of inhibitors through 3D database searching. Journal of Medicinal Chemistry 40: 920-929.
18. Nishizawa M, Yamagishi T, Dutschman GE, Parker WB, Bodner AJ, Kilkuskie RE, Cheng Y-C & Lee K-H (1989) Anti-AIDS agents, 1. Isolation and characterization of four new tetragalloylquinic acids as a new class of HIV reverse transcriptase inhibitors from tannic acid. Journal of Natural Products 52: 762-768.
19. Pommier Y, Pilon A, Bajaj K, Mazumder A & Neamati N (1997) HIV-1 integrase as a target for antiviral drugs. Antiviral Chemistry and Chemotherapy 8: 483-503.
20. Rice WG, Supko JG, Malspeis L, Buckheit RWJ, Clanton D, Bu M, Graham L, Schaeffer C, Turpin J, Domagala J, Gogliotti R, Bader JP, Halliday SM, Coren L, Sowder RC II, Arthur LO & Henderson LE (1995) Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS. Science 270: 1194-1197.
21. Rice P, Craigie R & Davies DR (1996a) Retroviral integrases and their cousins. Current Opinion in Structural Biology 6: 76-83.
22. Rice WG, Turpin JA, Schaeffer CA, Graham L, Clanton D, Buckheit RWJ, Zaharevitz D, Summers MF, Wallqvist A & Covell DG (1996b) Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc finger inhibitors. Journal of Medicinal Chemistry 39: 3606-3616.
23. Robinson WE Jr, Cordeiro M, Abdel-Malek S, Jia Q, Chow SA, Reinecke MG & Mitchell WM (1996a) Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase. Molecular Pharmacology 50: 846-855.
24. Robinson WE Jr, Reinecke MG, Abdel-Malek S, Jia Q & Chow SA (1996b) Inhibitors of HIV-1 replication that inhibit HIV integrase. Proceedings of the National Academy of Sciences, USA 93: 6326-6331.
25. Tummino PJ, Scholten JD, Harvey PJ, Holler TP, Maloney L, Gogliotti R, Domagala J & Hupe D (1996) The in vitro ejection of zinc from human immunodeficiency virus (HIV) type 1 nucleocapsid protein by disulfide benzamides with cellular anti-HIV activity. Proceedings of the National Academy of Sciences, USA 93: 969-673.
26. Turpin JA, Terpening SJ, Schaeffer CA, Yu G, Glover CJ, Felsted RL, Sausville EA & Rice WG (1996) Inhibitors of human immunodeficiency virus type 1 zinc fingers prevent normal processing of gag precursors and result in the release of noninfectious virus particles Journal of Virology 70: 6180-6189.
27. Weislow OW, Kiser R, Fine D, Bader J, Shoemaker RH & Boyd MR (1989) New soluble formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity. Journal of the National Cancer Institute 81: 577-586.
28. Zhao H, Neamati N, Hong H, Mazumder A, Wang S, Sunder S, Milne GWA, Pommier Y & Burke TR Jr (1997a) Coumarin-based inhibitors of HIV integrase. Journal of Medicinal Chemistry 40: 242-249.
29. Zhao H, Neamati N, Mazumder A, Sunder S, Pommier Y & Burke TR Jr (1997b) Arylamide inhibitors of HIV-1 integrase. Journal of Medicinal Chemistry 40: 1186-1194.
30. Zhao H, Neamati N, Sunder S, Hong H, Wang S, Milne GWA, Pommier Y & Burke TR Jr (1997c) Hydrazide-containing inhibitors of HIV-1 integrase. Journal of Medicinal Chemistry 40: 937-941